Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence

Rhabdomyosarcoma is a type of soft tissue cancer. Scientists at St. Jude Children's Research Hospital studied the population of cells that persists after therapy, causing rhabdomyosarcoma recurrence.

27 Apr 2022

New findings show rise in racial disparities as availability of proton beam therapy increased in the U.S.

Two new large studies led by researchers at the American Cancer Society (ACS) show an increase in the use of proton beam therapy (PBT) for patients with cancer in the United States during the past decade.

27 Apr 2022

Roswell Park experts to share latest advances in the treatment of blood-related cancers

Roswell Park Comprehensive Cancer Center specialists will share the latest advances and developments in the treatment of blood-related cancers at the 2022 Tandem Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood and Marrow Transplant Research (CIBMTR) in Salt Lake City, Utah, from April 23 to 26.

26 Apr 2022

Johns Hopkins scientists receive $7.8 million funding from Break Through Cancer

The Johns Hopkins Kimmel Cancer Center and the Departments of Gynecology/Obstetrics, Neurosurgery and Pathology have been awarded more than $7.8 million for novel, multicenter projects designed to intercept and find cures for several deadly cancers, including pancreatic cancer, ovarian cancer, and the brain cancer known as glioblastoma.

26 Apr 2022

Study uncovers the regulator of cancer ‘stemness’

The protein FOXK2 promotes survival of cancer stem cells in ovarian cancer, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.

26 Apr 2022

Low-cost wireless device could provide precise, safe treatment options for cancers

For those diagnosed with colorectal cancer, surgery has been the only option that offers a solution. Unfortunately, surgery is frequently complicated by disease recurrence at the site of the original cancer when microscopic cancer cells are left behind at the time of surgery.

26 Apr 2022

Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

Dotmatics was today announced as the formal name and brand for the combined entities of Insightful Science and Dotmatics.

From Dotmatics 26 Apr 2022

A potential way for overcoming immunotherapy resistance in patients with mucosal melanomas

The development of the anti-cancer immunotherapy drugs called immune checkpoint inhibitors has improved treatment for many cancer patients, but patients with mucosal melanomas - melanomas that occur not on the skin but in the mucous membranes in the head, neck, eyes, respiratory tract, and genitourinary region - are particularly resistant to immune checkpoint inhibitors for reasons researchers don't fully understand.

25 Apr 2022

Recipients for the 2022 NCCN Foundation Young Investigator Awards Program announced

The National Comprehensive Cancer Network and the NCCN Foundation today announced seven recipients for the 2022 NCCN Foundation Young Investigator Awards (YIA) Program.

25 Apr 2022

New data may change the standard of care for patients with advanced non-small cell lung cancer

The phase 2 clinical trial of a multi-center study known as the COAST clinical trial has demonstrated improved outcomes using immunotherapy combinations for patients with unresectable stage III non-small cell lung cancer, according to researchers at Yale Cancer Center and participating organizations.

25 Apr 2022

Researchers identify five types of bacteria in men with aggressive prostate cancer

Researchers at the University of East Anglia have found a link between bacteria and aggressive forms of prostate cancer.

25 Apr 2022

Less PSA testing minimizes overdiagnosis but may lead to increase in metastatic prostate cancer cases

Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate cancer.

22 Apr 2022

AI-based system improves bladder cancer treatment response assessment

In a small but multi-institutional study, an artificial intelligence-based system improved providers' assessments of whether patients with bladder cancer had complete response to chemotherapy before a radical cystectomy (bladder removal surgery).

22 Apr 2022

Researchers identify new factors that can predict breast cancer recurrence

Genetics and other factors that can determine if a woman is at risk for a recurrence of breast cancer have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing new research avenues for preventing a new tumor from developing.

22 Apr 2022

Could DNA be linked to Premature Aging in Cancer Survivors?

In this interview, we speak to Dr. Wang about his latest research that investigated accelerated aging in childhood cancer survivors and the underlying genetics causing this.

22 Apr 2022

Researchers test an experimental treatment for metastatic cancer

Researchers at the University of Oklahoma are testing an experimental treatment for metastatic cancer focusing on pancreatic cancer.

20 Apr 2022

DNA abnormality explains insensitivity to chemotherapy in germ cell cancer

Extra copies of a piece of DNA partly explain insensitivity to chemotherapy in germ cell cancer, a new study shows.

20 Apr 2022

CryoEM reveals never-before-seen details of the human androgen receptor

Scientists at Memorial Sloan Kettering Cancer Center (MSK) have glimpsed never-before-seen details of the human androgen receptor - the protein inside of cells that responds to male-typical hormones like testosterone.

20 Apr 2022

Newly discovered immune cell "soldier" could be a good target for immunotherapy

Despite the success of immunotherapy in helping many people with cancer, the majority of patients still do not respond to these treatments. There is need for continued research.

20 Apr 2022

Cancer survivors facing medical financial hardship have higher mortality risk

New findings from a large national study led by researchers at the American Cancer Society (ACS) show cancer survivors in the United States who reported medical financial hardship had a higher mortality risk than cancer survivors without financial hardship.

20 Apr 2022

Oncology News and Research

Further Reading

Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence

New findings show rise in racial disparities as availability of proton beam therapy increased in the U.S.

Roswell Park experts to share latest advances in the treatment of blood-related cancers

Johns Hopkins scientists receive $7.8 million funding from Break Through Cancer

Study uncovers the regulator of cancer ‘stemness’

Low-cost wireless device could provide precise, safe treatment options for cancers

Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

A potential way for overcoming immunotherapy resistance in patients with mucosal melanomas

Recipients for the 2022 NCCN Foundation Young Investigator Awards Program announced

New data may change the standard of care for patients with advanced non-small cell lung cancer

Researchers identify five types of bacteria in men with aggressive prostate cancer

Less PSA testing minimizes overdiagnosis but may lead to increase in metastatic prostate cancer cases

AI-based system improves bladder cancer treatment response assessment

Researchers identify new factors that can predict breast cancer recurrence

Could DNA be linked to Premature Aging in Cancer Survivors?

Researchers test an experimental treatment for metastatic cancer

DNA abnormality explains insensitivity to chemotherapy in germ cell cancer

CryoEM reveals never-before-seen details of the human androgen receptor

Newly discovered immune cell "soldier" could be a good target for immunotherapy

Cancer survivors facing medical financial hardship have higher mortality risk

Event guide: 10th CAR-TCR Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News